Introduction: The Government of Bangladesh has been carrying out a national cervical and breast cancer screening programme on women aged 30 to 60 years since 2005 using the ‘VIA (Visual Inspection of Cervix with Acetic Acid)’ and ‘Clinical Breast Examination (CBE)’ screening methods respectively. Initially, paper-based aggregated data were collected from all health facilities down to the upazila (sub-district) level. The data collection system was transformed to an electronic method in 2013 using District Health Information System (DHIS2) and  In 2018, side by side maintaining the aggregated data collection system, a case-based electronic data registry system was also established using the DHIS2 platform, and registration was rolled out down to the grassroots level at community clinics. The case-based system maintains a personal electronic profile for every participating woman and updates her screening results, treatment, and follow-up data. 

Methods: This study reported the electronic cervical cancer screening data covering the years 2018 to 2023. Women aged 30 to 60 were enrolled in the DHIS2 electronic registry in health facilities of all tiers and screened for cervical cancer using the VIA method. The VIA-positive women had their colposcopy in the nearest colposcopy centres. During each encounter, required data were captured in DHIS2. 

Results: In 6,895 health facilities, 1,562,963 women were enrolled. Among them, 1,557,002 (99.6%) availed VIA tests at 1,094 centres. Primary healthcare facilities performed 74.4% enrolments and 72% VIA tests. 51,913 (3.3%) women were VIA-positive, of which only 20,954 (40.4%) attended for colposcopy. 

Conclusions: The sustainable national cervical cancer screening and treatment programme for women in Bangladesh using an effective DHIS2-based electronic case-based tracking system can be a valuable lesson for other countries.